Loading
Latest filing published 21 Jan 2026 for Jaguar Health, Inc..
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Jonathan S. Wolin (senior executive) discloses dealings in Jaguar Health, Inc. to SEC (Form 4). In total, 9 filings cover trades dated from 5 April 2022 to 11 December 2025.
The open-market record is one-sided, with 1 purchase worth €9 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 3 share grants and 5 option exercises.
The latest filing, published on 21 January 2026, reports a share grant in Jaguar Health, Inc. The last purchase on record was published on 3 January 2023, which is 1,390 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations